Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FD9R5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VYNDAMAX 61 MG Capsule UD 30S, a pharmaceutical product used in the treatment of cardiac amyloidosis. The contract, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp leverages its comprehensive IDC to fulfill diverse healthcare requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price structure and relatively short performance timeline reflect typical delivery order characteristics under the DLA's pharmaceutical prime vendor program, which prioritizes rapid fulfillment of specific medical supply needs. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its established capability to meet competitive federal procurement standards and support military medical supply chain operations across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FD9R5?
SPE2DB25FD9R5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FD9R5 worth?
The government has obligated $13,847 on SPE2DB25FD9R5.
Is contract SPE2DB25FD9R5 an order under another contract?
Yes. SPE2DB25FD9R5 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD9R5 competed?
The extent of competition for SPE2DB25FD9R5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award